Zydus Lifesciences Rises as Subsidiary Launches Generic Veterinary Drug in US
Mumbai, September 16 (Patrika English News). Shares of Zydus Lifesciences edged higher on Tuesday after its step-down wholly owned subsidiary, ZyVet Animal Health, launched the first FDA-approved generic of phenylpropanolamine hydrochloride tablets in the United States. The stock opened at ₹1,037.35 on the BSE and touched a high of ₹1,043.35 before trading at ₹1,038.35, up … Read more
